Advertisement
Loading...

Helix BioPharma Corp.

HBPCF•PNK
Healthcare
Biotechnology
$1.71
$-0.02(-1.16%)
U.S. Market is Open • 15:45

Helix BioPharma Corp. (HBPCF) Stock Overview

Explore Helix BioPharma Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap130.6M
P/E Ratio-42.28
EPS (TTM)$-0.04
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$1.81
3 Months$2.47
1 Year Target$2.17

HBPCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Helix BioPharma Corp. (HBPCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $2.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -42.28 and a market capitalization of 130.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.16%
5-Day Change
-1.16%
1-Month Change
-1.16%
3-Month Change
-1.16%
6-Month Change
-1.16%
Year-to-Date (YTD) Change
-1.16%
1-Year Change
185.00%
3-Year Change
135.86%
5-Year Change
-55.24%
All-Time (Max) Change
-83.94%

Contact Information

https://www.helixbiopharma.com
+1 905 841 2300
401 Bay Street, Toronto, ON, M5H 2Y4

Company Facts

7 Employees
IPO DateNov 27, 2009
CountryCA
Actively Trading

Frequently Asked Questions